Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis

INTRODUCTION: Allergen immunotherapy (AIT) is the only disease-modifying treatment option available for patients with IgE-mediated allergic rhinitis. The identification of specific biomarkers, which may predict response to AIT, is currently an active field of research in the aspect of recommended pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jura-Szołtys, Edyta, Gawlik, Radosław, Branicka, Olga, Stryjewska-Makuch, Grażyna, Glück, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837575/
https://www.ncbi.nlm.nih.gov/pubmed/36686010
http://dx.doi.org/10.5114/ada.2022.117978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837575/
https://www.ncbi.nlm.nih.gov/pubmed/36686010
http://dx.doi.org/10.5114/ada.2022.117978

Ejemplares similares